Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Henry Ford Health System
With
American Cancer Society, Inc.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed prostate adenocarcinoma.
Patients with low or favorable intermediate risk prostate cancer and patients with unfavorable intermediate risk prostate cancer who decline androgen deprivation therapy
Pretreatment evaluations must be completed as specified in Section 4.0
Patients must sign a study-specific informed consent form prior to study participation.
No contraindication to MRI. For example, patients with metal fragments or implanted devices such as pacemakers and aneurysm clips may not be eligible for the study
At least one intraprostatic lesion can be identified on the mpMR images.
Patients agree to have hydrogel placed.
Clareo Health | Phase I Study MR-guided SBRT to PCa
